Principal Investigator: Sarah Fowler, Ph.D.
his project includes three multicenter trials of the safety
and accuracy of prenatal diagnosis procedures, chorionic villus
sampling and amniocentesis: 1) a nonrandomized comparison of Transcervical
(TC) CVS and amniocentesis procedures in 8,000 obstetrical patients
at 7 clinics which found an estimated excess risk of pregnancy
loss after TC CVS compared with amniocentesis of 0.8% (NEJM, 1989);
2) a randomized Transabdominal (TA) vs. Transcervical (TC) CVS
study of 4000 patients at 8 clinics which revealed low overall
pregnancy loss rates and indicated that when practitioners are
experienced, the two methods are equally safe (NEJM, 1992); 3)
a study of 3,000 Danish patients randomized between amniocentesis,
TA and TC CVS which found risk of fetal loss was similar after
TA CVS and amniocentesis procedures, but was considerably greater
following TC CVS (Lancet, 1992). NICHD Cooperative Agreement,
1984-1992.
|